MRGPRX2 and rheumatoid arthritis: As these were reported to be involved in the main signaling pathways of MRGPRX236, which explains mast cell activation in many non-IgE-mediated diseases, we speculated that synovial mast cell activation in RA patients was mediated by MRGPRX2.